Clinical trial · Observational
Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
NCT02095912CI-TRIAL-00023419completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To identify risk factors for aggressiveness in Squamous Cell Carcinoma of the skin in organ transplant recipients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Squamous Cell Carcinoma | Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Diameter of Squamous Cell Carcinoma
- timeFrame
- 1 year
- description
- * Location * exact size in mm * histological classification (well-differentiated, moderately-differentiated, poorly differentiated, spindle cell morphology, desmoplastic, basi-squamous, acantholytic) * Invasion * rapid growth * local recurrence * sentinel node sampling * Metastasis
Secondary outcomes (1)
- measure
- Sun exposure history
- timeFrame
- 1 year
- description
- * skin type * hair colour * eye colour * freckles * cumulative UV exposure Measurements will be assessed with questionnaire from about 150 participants.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: Organ transplant recipients with: * \> 9 SCC in total or * \> 2 SCC per year (in any one year) or * any single "index" SCC that has a very poorly differentiated cell morphology or that behaved aggressively in Terms of local recurrence or local/systemic metastasis Exclusion Criteria: * Non organ transplant recipients
References
Publications (0)
Data not yet available
No reference posted for this study.